View ValuationInteger Holdings 향후 성장Future 기준 점검 1/6Integer Holdings (는) 각각 연간 7.1% 및 3.8% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 8.1% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 12.2% 로 예상됩니다.핵심 정보7.1%이익 성장률8.09%EPS 성장률Medical Equipment 이익 성장15.8%매출 성장률3.8%향후 자기자본이익률12.25%애널리스트 커버리지Good마지막 업데이트06 May 2026최근 향후 성장 업데이트공지 • May 03Integer Holdings Corporation Announces Earnings Guidance for the Year 2026Integer Holdings Corporation announced earnings guidance for the year 2026. For the year, the company expects as reported sales in the range of $1,805 million to $1,835 million decrease of 3% to 1% as compared to previous year, operating income in the range of $165 million to $185 million decrease of 25% to 16% as compared to previous year, net income in the range of $105 million to $125 million increase of 2% to 21% as compared to previous year, and diluted earnings per share in the range of $3.07 to $3.64 increase of 6% to 26% as compared to previous year.Price Target Changed • Feb 22Price target increased by 7.4% to US$91.88Up from US$85.57, the current price target is an average from 8 analysts. New target price is 8.3% above last closing price of US$84.85. Stock is down 35% over the past year. The company is forecast to post earnings per share of US$4.19 for next year compared to US$2.96 last year.공지 • Feb 19Integer Holdings Corporation Provides Earnings Guidance for the Year 2026Integer Holdings Corporation provided earnings guidance for the year 2026. For the year, the company expects as reported sales in the range of $1,826 million to $1,876 million, operating income in the range of $184 million to $204 million, net income in the range of $121 million to $138 million, and diluted earnings per share in the range of $3.53 to $4.01.Price Target Changed • Oct 24Price target decreased by 38% to US$86.00Down from US$139, the current price target is an average from 7 analysts. New target price is 18% above last closing price of US$72.91. Stock is down 42% over the past year. The company is forecast to post earnings per share of US$2.80 for next year compared to US$3.60 last year.공지 • Oct 23+ 1 more updateInteger Holdings Corporation Provides Earnings Guidance for the Year 2026 and Year 2027Integer Holdings Corporation provided earnings guidance for the year 2026 and year 2027. For the year 2026, the company expects Reported sales to be down 2% to up 2% and Organic sales to be flat to up 4%. For the year 2027, the company expects growth 200 basis points above market.공지 • Apr 25Integer Holdings Corporation Provides Earnings Guidance for the Year 2025Integer Holdings Corporation provided earnings guidance for the year 2025. For the year, the company expects sales in the range of $1,846 million to $1,880 million, Operating income in the range of $242 million to $258 million, Income from continuing operations of $108 million to $120 million, Diluted earnings per share in the range of $3.00 to $3.36.모든 업데이트 보기Recent updates실시간 뉴스 • May 05Integer Holdings Considers Sale or Merger Following Q1 Profit and Lowered 2026 OutlookInteger reported income from continuing operations of $16.5 million in Q1 2026, compared with a prior-year loss of $22.5 million, alongside modest sales growth. The board has launched a broad review of options including a potential sale, merger or business combination, supported by Goldman Sachs and Davis Polk & Wardwell. Q1 2026 revenue and adjusted EPS were ahead of market expectations, but full-year 2026 revenue guidance was cut to about $1.82b and adjusted EPS guidance was lowered due to product rollout issues and revised customer demand. For you as an investor, the key tension is between improved quarterly profitability and the more cautious outlook for the rest of 2026. Management pointed to three new product rollouts and updated customer demand forecasts as the main reasons for trimming guidance, along with a weaker operating margin compared with last year. The company also expects reported sales to be slightly lower for 2026, with organic sales flat to down 1%, tied to temporary normalization in the electrophysiology market rather than contract losses or supply changes. At the same time, the board’s decision to review “all potential opportunities” reflects external interest in the business and a willingness to consider structural changes. This process can introduce uncertainty around execution, stock price volatility and potential impacts on the balance sheet, and there is no timeline or assurance that a transaction will occur. Investors may want to watch for updates on the review, further commentary on the electrophysiology market, and progress on integrating the three tuck-in acquisitions completed since early 2025.공지 • May 03Integer Holdings Corporation Announces Earnings Guidance for the Year 2026Integer Holdings Corporation announced earnings guidance for the year 2026. For the year, the company expects as reported sales in the range of $1,805 million to $1,835 million decrease of 3% to 1% as compared to previous year, operating income in the range of $165 million to $185 million decrease of 25% to 16% as compared to previous year, net income in the range of $105 million to $125 million increase of 2% to 21% as compared to previous year, and diluted earnings per share in the range of $3.07 to $3.64 increase of 6% to 26% as compared to previous year.Reported Earnings • May 01First quarter 2026 earnings: Revenues exceed analysts expectations while EPS lags behindFirst quarter 2026 results: EPS: US$0.48 (up from US$0.66 loss in 1Q 2025). Revenue: US$439.6m (flat on 1Q 2025). Net income: US$16.5m (up US$39.0m from 1Q 2025). Profit margin: 3.8% (up from net loss in 1Q 2025). Revenue exceeded analyst estimates by 3.2%. Earnings per share (EPS) missed analyst estimates by 26%. Revenue is forecast to grow 3.8% p.a. on average during the next 3 years, compared to a 7.9% growth forecast for the Medical Equipment industry in the US. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.내러티브 업데이트 • Apr 20ITGR: Fair View Expects 2026 Product Drag To Fade As Pipeline BuildsAnalysts have lifted their price targets on Integer Holdings to a range of about $92 to $101, reflecting updated views on the timing of headwinds from underperforming products and the potential contribution from new products after 2026. Analyst Commentary Recent price target revisions cluster in a range of about $92 to $101, which signals that analysts see room for upside but also recognize execution questions around product transitions and growth consistency.공지 • Apr 08Integer Holdings Corporation, Annual General Meeting, May 20, 2026Integer Holdings Corporation, Annual General Meeting, May 20, 2026. Location: hilton dallas/plano granite park hotel, 5805 granite parkway, plano, plano United States공지 • Apr 07Integer Holdings Corporation Announces Pamela G. Bailey, Independent Chair of the Board Will Not Stand for Re-Election At 2026 AGMInteger Holdings Corporation announced Pamela G. Bailey, who currently serves as Integer’s independent Chair of the Board, will not stand for re-election at the Company’s 2026 Annual Meeting of Stockholders, scheduled for May 20, 2026.내러티브 업데이트 • Apr 05ITGR: Fair View Sees 2026 Headwinds Easing As Newer Products Gain TractionAnalysts have raised Integer Holdings' implied price target range to about $92 to $101. This reflects updated views that near term product headwinds could ease by 2026, supported by contributions from newer products.공지 • Apr 02Integer Holdings Corporation to Report Q1, 2026 Results on Apr 30, 2026Integer Holdings Corporation announced that they will report Q1, 2026 results Pre-Market on Apr 30, 2026내러티브 업데이트 • Mar 20ITGR: Fair View Sees 2026 Product Headwinds Easing As Recovery ProgressesAnalysts have nudged their price expectations for Integer Holdings higher, with the updated fair value moving from $92.63 to $93.25 as they factor in recent target increases and ongoing work to address product headwinds and potential future growth drivers. Analyst Commentary Bullish Takeaways Bullish analysts see the higher price targets, now clustered in the low to low triple digits, as recognition that recent headwinds are already reflected in expectations and that current valuation assumes a measured recovery path.공지 • Mar 12Integer Holdings Corporation Announces Board Changes, Effective March 12, 2026Integer Holdings Corporation has appointed two new directors to its Board of Directors: James F. Flanagan and Aaron Kapito. These appointments are effective as of March 12, 2026, and the board size has been increased to 13 members. The Cooperation Agreement also stipulates that two incumbent directors will not stand for re-election at the 2026 Annual Meeting of Stockholders. The agreement includes provisions for the appointment of the new directors to specific board committees, including the Audit Committee, the Compensation and Organization Committee, and the Technology Strategy Committee. The Cooperation Agreement includes voting commitments, standstill restrictions, and mutual non-disparagement provisions, which remain in place until the earlier of 30 days prior to the advance notice deadline for the 2027 Annual Meeting or one year from the effective date of the agreement. Mr. Flanagan is the former Chief Operating Officer of PwC from 2014 to 2021, bringing proven diversified, strategic, operational and qualified financial expertise through 39 years of increasing client and management roles. Previously, he also served as PwC’s US Financial Services Practice Leader from 2006 to 2014, and prior to that as the Transaction Services Leader from 2001 to 2006 and Transaction Services Partner from 1994 to 2001. He has served on the Board of Directors at Belami Ecommerce, a subsidiary of SkyX Platforms Corp. from 2022 to 2025, while also serving as Audit Committee Chair. Mr. Flanagan received a B.S. in Accounting from the C.W. Post School of Professional Accountancy at Long Island University. Mr. Kapito is a Partner at Politan Capital Management L.P., an investment management firm that he co-founded in 2021. Previously, Mr. Kapito served as a Senior Analyst at Lion Point Capital from 2018 to 2021, a Senior Analyst and founding member of Delonix Capital from 2016 to 2017, and an Associate Portfolio Manager for Elliott Management L.P. from 2011 to 2016. Mr. Kapito currently serves on the boards of Rocky Mountain Steel Mills, a manufacturer of high-performance steel products, and Associated Veterinary Partners, a veterinary clinic platform. Mr. Kapito received a B.S. in Economics from the Wharton School at the University of Pennsylvania and an M.B.A. from Harvard Business School.내러티브 업데이트 • Mar 06ITGR: Fair View Balances 2026 Product Headwinds And New Launch RecoveryNarrative Update Analysts have lifted their blended price target on Integer Holdings to $92.63 from $85.57, citing updated views on future P/E, revenue growth headwinds tied to a few underperforming products and an eventual recovery supported by new product contributions. Analyst Commentary Recent research has focused on how Integer balances valuation against execution risks tied to specific product headwinds and future growth ambitions.Recent Insider Transactions Derivative • Mar 03CEO, President & Director exercised options and sold US$1.5m worth of stockOn the 24th of February, Payman Khales exercised options to acquire 17k shares at no cost and sold these for an average price of US$87.10 per share. This trade did not impact their existing holding. For the year to December 2019, Payman's total compensation was 28% salary and 72% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since March 2025, Payman's direct individual holding has increased from 19.74k shares to 25.47k. Company insiders have collectively sold US$13m more than they bought, via options and on-market transactions in the last 12 months.New Risk • Feb 22New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 42% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (17% operating cash flow to total debt). Minor Risk Large one-off items impacting financial results.Price Target Changed • Feb 22Price target increased by 7.4% to US$91.88Up from US$85.57, the current price target is an average from 8 analysts. New target price is 8.3% above last closing price of US$84.85. Stock is down 35% over the past year. The company is forecast to post earnings per share of US$4.19 for next year compared to US$2.96 last year.Reported Earnings • Feb 20Full year 2025 earnings: EPS exceeds analyst expectationsFull year 2025 results: EPS: US$2.96 (down from US$3.60 in FY 2024). Revenue: US$1.85b (up 8.0% from FY 2024). Net income: US$102.8m (down 15% from FY 2024). Profit margin: 5.5% (down from 7.1% in FY 2024). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 3.3%. Revenue is forecast to grow 4.1% p.a. on average during the next 3 years, compared to a 7.8% growth forecast for the Medical Equipment industry in the US. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.내러티브 업데이트 • Feb 19ITGR: Fair Value Holds As FY26 Reacceleration Faces Confidence RebuildAnalysts have trimmed their price target on Integer Holdings to $86 from $88, citing expectations that it may take a few quarters before investors gain confidence in a potential reacceleration discussed for the second half of FY26. Analyst Commentary Recent research reflects a slightly more cautious stance on Integer Holdings, with the price target adjusted to $86 from $88.공지 • Feb 19Integer Holdings Corporation Provides Earnings Guidance for the Year 2026Integer Holdings Corporation provided earnings guidance for the year 2026. For the year, the company expects as reported sales in the range of $1,826 million to $1,876 million, operating income in the range of $184 million to $204 million, net income in the range of $121 million to $138 million, and diluted earnings per share in the range of $3.53 to $4.01.내러티브 업데이트 • Feb 05ITGR: Fair Value Holds As 2026 Reacceleration Awaits Coatings Asset IntegrationAnalysts reduced their price target for Integer Holdings to US$86 from US$88, citing expectations that it may take a few quarters before investors are comfortable underwriting a potential re acceleration in the second half of FY26. Analyst Commentary Bullish Takeaways Bullish analysts maintain a positive stance on the shares, suggesting they still see support for the current valuation even with a slightly lower price target.Seeking Alpha • Feb 04Integer Holdings: Poor Uptake Of Certain Products Adversely Affecting StockSummary Integer Holdings is maintained at 'Hold' due to deteriorating fundamentals and bearish technical trends. Integer's Q3 earnings beat expectations, but a surprise guidance cut for 2026 triggered a sharp sell-off. Reduced 2026 sales outlook, driven by poor uptake of key products, has shaken investor confidence in future demand. Management's cost-cutting supports near-term profitability, but the market remains wary pending Q4 results and an updated outlook. Read the full article on Seeking Alpha공지 • Jan 28Integer Holdings Corporation to Highlight Integrated R&D Solutions and Expanded Coating Capabilities During Md&M West 2026Integer Holdings Corporation will exhibit during MD&M West 2026 in Anaheim, Calif., Feb. 3 - 5. Integer will unveil a significantly expanded 20 x 50 sq. ft. new booth #3201, showcasing the company's full range of customer solutions. On prominent display will be R&D Velocity, Integer's integrated R&D ecosystem connecting design, prototyping and manufacturing to help medical device companies develop products that are manufacturable from the start, accelerating the time between design and manufacturability. The company will showcase several solutions - delivered through a network of locations globally - that are central to R&D Velocity, including: Differentiated Technology Platforms: Proven product technologies that enable, accelerate and de-risk the development of customers' next generation devices. Global Capabilities and Expertise: Specialized labs and integrated manufacturing all in one ecosystem along with dedicated engineers and global centers of excellence to accelerate every phase of development. Ease of Manufacturability: Designs optimized early to scale seamlessly, reducing rework and accelerating launch. Rapid Prototyping: Engineer-to-engineer collaboration delivering prototypes in as little as two weeks. Integer will additionally highlight a range of key product areas and innovations during MD&M West, including: Integer Medical Coatings: The company continues to expand its role as a fully integrated coating partner for medical devices, strengthening its ability to deliver end-to-end surface-modification solutions. Integer will also showcase its full coatings portfolio, including PTFE, PTFE alternatives, hydrophilic coatings, parylene, and advanced surface-modification technologies. Following the acquisitions of Precision Coating,VSi Parylene, and certain Biocoat assets last year, Integer has further strengthened its position as a fully integrated coating partner For medical devices. Cardiac Rhythm Management and Neuromodulation: Miniaturized technologies for finished IPG systems, as well as Gen 3 Li-Ion and Gen 2 CFx batteries. Cardio and Vascular: A full range of electrophysiology, structural heart, and neurovascular product solutions including complex catheters, guidewires, steerable introducers and sheaths, therapy delivery systems and implant technologies.공지 • Jan 22Integer Holdings Corporation to Report Q4, 2025 Results on Feb 19, 2026Integer Holdings Corporation announced that they will report Q4, 2025 results Pre-Market on Feb 19, 2026내러티브 업데이트 • Jan 21ITGR: Fair Value Suggests Recovery As 2026 Demand Visibility Gradually ImprovesAnalysts have modestly trimmed their blended price target for Integer Holdings to about $86, down from prior targets clustered closer to $88 and above. This reflects caution around the company's softer 2026 outlook and reduced visibility on the timing of any potential demand recovery.내러티브 업데이트 • Jan 07ITGR: Fair Value Suggests Shares Will Recover As 2026 Visibility ImprovesAnalysts have inched their fair value estimate for Integer Holdings higher to about US$85.57 from roughly US$84.29, reflecting lower assumed discount rates and a slightly higher future P/E multiple. This follows recent research updates that cut price targets and ratings but still highlight the potential for recovery once revenue visibility improves.내러티브 업데이트 • Dec 17ITGR: Shares Will Recover As 2026 Demand Visibility And Orders Gradually StabilizeThe analyst price target for Integer Holdings has been trimmed modestly, with analysts citing reduced 2026 visibility, order and demand headwinds across several newer product launches, and a longer wait for growth reacceleration as reasons for resetting expectations, even as they see the recent share price pullback as overdone. Analyst Commentary Bullish analysts acknowledge the near term reset to expectations but argue that the recent compression in Integer Holdings valuation already discounts a prolonged period of slower growth and execution risk.공지 • Dec 11Saxena White P.A. Files Securities Fraud Class Action Against Integer Holdings Corporation and Certain of its ExecutivesSaxena White P.A. has filed a securities fraud class action lawsuit (the “Class Action”) in the United States District Court for the Southern District of New York against Integer Holdings Corporation (“Integer” or the “Company”) and certain of its executive officers (collectively, “Defendants”). The Class Action asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and U.S. Securities and Exchange Commission (“SEC”) Rule 10b-5 promulgated thereunder on behalf of all persons or entities that purchased Integer common stock between July 25, 2024 and October 22, 2025, inclusive (the “Class Period”), and were damaged thereby (the “Class”). The Class Action filed by Saxena White is captioned West Palm Beach Firefighters’ Pension Fund v. Integer Holdings Corporation, et al., No. 25-cv-10251 (S.D.N.Y.).Based in Plano, Texas, Integer purports to be one of the medical device contract development and manufacturing organizations in the world. The Company contracts with medical device companies to manufacture cardiac rhythm management and cardio and vascular (“C&V”) medical devices. Integer’s C&V product line generates approximately 60% of the Company’s total revenue. As a part of the C&V product line, Integer manufactures electrophysiology (“EP”) devices, which diagnose and map the heart’s electrical activity to address problems such as irregular heartbeats (cardiac arrhythmias).Prior to the Class Period, EP devices underwent a technological revolution as Integer customers began to develop devices for pulse field ablation (“PFA”) procedures that use brief, high-energy electrical pulses to treat atrial fibrillation. In turn, the industry became increasingly focused on integrating EP devices and PFA platforms to effectuate a more seamless cardiac procedure. As a result, EP devices represented a significant growth driver for Integer’s C&V segment. Leading up to the Class Period, CEO Dziedzic described PFA platforms as “a tailwind” due to the Company’s “vertically integrated offering[,]” while also touting that Integer “benefit[ed] significantly from electrophysiology procedure growth.” CEO Dziedzic further explained, “We participate in the full procedure, which is one of the strengths of Integer.” The Class Action alleges that, during the Class Period, Defendants made materially false and/or misleading statements and failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose that: (1) Integer materially overstated its competitive position within the growing EP manufacturing market; (2) despite Integer’s claims of strong visibility into customer demand, the Company was experiencing a sustained deterioration in sales relating to two of its EP devices; (3) in turn, Integer mischaracterized its EP devices as a long-term growth driver for the Company’s C&V segment; (4) as a result of the above, Defendants’ positive statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.내러티브 업데이트 • Dec 03ITGR: Shares Will Recover As 2026 Demand Visibility Gradually ImprovesAnalysts have trimmed their price target on Integer Holdings slightly, to about $84.57 from roughly $84.86, as they factor in softer near term visibility and delayed confidence in a second half 2026 re acceleration, despite longer term optimism about the company’s recovery and customer relationships. Analyst Commentary Street research following Integer Holdings recent update reflects a sharply reset near term outlook, but also a degree of longer term confidence in the company’s strategic positioning and customer relationships.내러티브 업데이트 • Nov 19ITGR: Shares Will Recover As Order Headwinds Are ResolvedInteger Holdings' average analyst price target has sharply decreased, dropping from above $120 to a range of $77 to $88. Analysts cite concerns that recent order shifts, lowered guidance, and uncertainty in the 2026 outlook justify a reset in valuation expectations for the stock.분석 기사 • Nov 06What You Can Learn From Integer Holdings Corporation's (NYSE:ITGR) P/E After Its 35% Share Price CrashInteger Holdings Corporation ( NYSE:ITGR ) shareholders that were waiting for something to happen have been dealt a...분석 기사 • Nov 05Some May Be Optimistic About Integer Holdings' (NYSE:ITGR) EarningsThe most recent earnings report from Integer Holdings Corporation ( NYSE:ITGR ) was disappointing for shareholders...공지 • Nov 05Integer Holdings Corporation (NYSE:ITGR) announces an Equity Buyback for $200 million worth of its shares.Integer Holdings Corporation (NYSE:ITGR) announces a share repurchase program. Under the program, the company will repurchase up to $200 million worth of its common stock. The company intends to primarily utilize cash on hand and free cash flows to fund the share repurchase program. The program has no expiration date.내러티브 업데이트 • Nov 05ITGR: Shares Will Recover As Demand Normalizes And Inventory Pressures EaseInteger Holdings’ analyst price target has been revised significantly lower, dropping from approximately $137 to $85 per share. Analysts cite headwinds from reduced revenue growth expectations and a weaker 2026 outlook following order changes to three key products.Buy Or Sell Opportunity • Oct 30Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 41% to US$63.32. The fair value is estimated to be US$80.00, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 13%. Revenue is forecast to grow by 5.6% in 2 years. Earnings are forecast to grow by 106% in the next 2 years.Reported Earnings • Oct 24Third quarter 2025 earnings: EPS misses analyst expectationsThird quarter 2025 results: EPS: US$1.13 (up from US$1.08 in 3Q 2024). Revenue: US$467.7m (up 8.4% from 3Q 2024). Net income: US$39.7m (up 9.4% from 3Q 2024). Profit margin: 8.5% (up from 8.4% in 3Q 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 7.0%. Revenue is forecast to grow 3.8% p.a. on average during the next 3 years, compared to a 8.4% growth forecast for the Medical Equipment industry in the US. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.Price Target Changed • Oct 24Price target decreased by 38% to US$86.00Down from US$139, the current price target is an average from 7 analysts. New target price is 18% above last closing price of US$72.91. Stock is down 42% over the past year. The company is forecast to post earnings per share of US$2.80 for next year compared to US$3.60 last year.공지 • Oct 24+ 1 more updateInteger Holdings Corporation Announces CEO Changes, Effective October 24, 2025Integer Holdings Corporation appointed Payman Khales as Chief Executive Officer, effective October 24, 2025. He succeeds Joseph Dziedzic, who is retiring after eight years of distinguished service as Integer President and CEO and will continue to serve as an advisor through March 31, 2026, to support a smooth transition. Mr. Khales joined Integer in 2018 as President of the Cardio & Vascular business, where he led a successful market- and customer-focused strategy, doubling sales in seven years and driving above-market growth, while further improving service levels and profitability. Most recently, as Chief Operating Officer, he oversaw both of Integer's business units and its global operations, further strengthening Integer's reputation as a strategic partner to medical device companies and OEMs worldwide. Prior to joining Integer, Mr. Khales held senior leadership roles at CECO Environmental Corp. and Ingersoll Rand Company. He holds an Executive MBA from Indiana University's Kelley School of Business and a Bachelor of Science in Mechanical Engineering from cole Polytechnique de Montréal. As previously disclosed, also effective October 24, 2025, Mr. Dziedzic will serve as a Special Advisor for the Company until March 31, 2026, to assist Mr. Khales with transition matters.공지 • Oct 23+ 1 more updateInteger Holdings Corporation Provides Earnings Guidance for the Year 2026 and Year 2027Integer Holdings Corporation provided earnings guidance for the year 2026 and year 2027. For the year 2026, the company expects Reported sales to be down 2% to up 2% and Organic sales to be flat to up 4%. For the year 2027, the company expects growth 200 basis points above market.내러티브 업데이트 • Oct 22Analysts Lower Integer Holdings Price Target Amid Cautious Sector Outlook and Stable Growth ProjectionsAnalysts have lowered their price target for Integer Holdings from $137.00 to $121.00, citing market volatility concerns and a cautious outlook for new investment within the MedTech sector, even as expectations remain for healthy quarterly performance. Analyst Commentary Recent analyst notes provide a balanced view of Integer Holdings, with both optimism and caution expressed regarding the company’s outlook and sector dynamics.공지 • Sep 25Integer Holdings Corporation to Report Q3, 2025 Results on Oct 23, 2025Integer Holdings Corporation announced that they will report Q3, 2025 results Pre-Market on Oct 23, 2025분석 기사 • Sep 09Is It Too Late To Consider Buying Integer Holdings Corporation (NYSE:ITGR)?While Integer Holdings Corporation ( NYSE:ITGR ) might not have the largest market cap around , it received a lot of...분석 기사 • Aug 12What You Can Learn From Integer Holdings Corporation's (NYSE:ITGR) P/EWith a price-to-earnings (or "P/E") ratio of 44.1x Integer Holdings Corporation ( NYSE:ITGR ) may be sending very...분석 기사 • Jul 22We Think Integer Holdings (NYSE:ITGR) Can Stay On Top Of Its DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...공지 • Jul 11Integer Holdings Corporation Appoints Michael Coyle to Board of DirectorsInteger Holdings Corporation announced it has appointed Michael Coyle to its Board of Directors. Coyle brings more than 40 years of leadership in the medical device industry to Integer and joins the Board as a member of the Audit Committee, Compensation & Organization Committee, and Technology Strategy Committee. He most recently served as president and CEO of iRhythm Technologies. Before that, he was executive vice president and group president of Medtronic’s cardio and vascular group and held leadership roles at St. Jude Medical and Eli Lilly earlier in his career. Coyle is currently a director on the Haemonetics Corporation and BaroPace boards and previously held positions on the boards of VNUS Medical Technologies Inc. and Volcano Corporation. He earned a master's degree in business administration from the Wharton School of Business, University of Pennsylvania, and a bachelor's degree from Case Western Reserve University. He additionally holds six U.S. patents related to cardiovascular medical device products and technologies.분석 기사 • Jul 08Integer Holdings Corporation (NYSE:ITGR) Shares Could Be 30% Below Their Intrinsic Value EstimateKey Insights Integer Holdings' estimated fair value is US$167 based on 2 Stage Free Cash Flow to Equity Integer...공지 • Jun 30+ 5 more updatesInteger Holdings Corporation(NYSE:ITGR) dropped from Russell 3000 Value IndexInteger Holdings Corporation(NYSE:ITGR) dropped from Russell 3000 Value Index공지 • Jun 26Integer Holdings Corporation to Report Q2, 2025 Results on Jul 24, 2025Integer Holdings Corporation announced that they will report Q2, 2025 results at 8:00 AM, US Eastern Standard Time on Jul 24, 2025분석 기사 • Jun 25Returns On Capital At Integer Holdings (NYSE:ITGR) Have StalledTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'll want to...Recent Insider Transactions Derivative • Jun 05Independent Director notifies of intention to sell stockDonald Spence intends to sell 15k shares in the next 90 days after lodging an Intent To Sell Form on the 4th of June. If the sale is conducted around the recent share price of US$120, it would amount to US$1.8m. Since March 2025, Donald has owned 18.78k shares directly. Company insiders have collectively sold US$12m more than they bought, via options and on-market transactions in the last 12 months.Buy Or Sell Opportunity • May 28Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 3.6% to US$119. The fair value is estimated to be US$151, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 15%. Revenue is forecast to grow by 17% in 2 years. Earnings are forecast to grow by 166% in the next 2 years.분석 기사 • May 25Is Now The Time To Look At Buying Integer Holdings Corporation (NYSE:ITGR)?Integer Holdings Corporation ( NYSE:ITGR ), might not be a large cap stock, but it saw a double-digit share price rise...분석 기사 • May 02Some May Be Optimistic About Integer Holdings' (NYSE:ITGR) EarningsShareholders appeared unconcerned with Integer Holdings Corporation's ( NYSE:ITGR ) lackluster earnings report last...Buy Or Sell Opportunity • Apr 30Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 12% to US$126. The fair value is estimated to be US$158, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 15%. Revenue is forecast to grow by 17% in 2 years. Earnings are forecast to grow by 166% in the next 2 years.New Risk • Apr 27New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 36% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (17% operating cash flow to total debt). Minor Risk Large one-off items impacting financial results.Reported Earnings • Apr 25First quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behindFirst quarter 2025 results: US$0.66 loss per share (down from US$0.61 profit in 1Q 2024). Revenue: US$437.4m (up 5.4% from 1Q 2024). Net loss: US$22.5m (down 210% from profit in 1Q 2024). Revenue exceeded analyst estimates by 2.0%. Earnings per share (EPS) missed analyst estimates. Revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 7.9% growth forecast for the Medical Equipment industry in the US. Over the last 3 years on average, earnings per share has increased by 16% per year whereas the company’s share price has increased by 18% per year.공지 • Apr 25Integer Holdings Corporation Provides Earnings Guidance for the Year 2025Integer Holdings Corporation provided earnings guidance for the year 2025. For the year, the company expects sales in the range of $1,846 million to $1,880 million, Operating income in the range of $242 million to $258 million, Income from continuing operations of $108 million to $120 million, Diluted earnings per share in the range of $3.00 to $3.36.공지 • Apr 24+ 1 more updateInteger Holdings Corporation Announces CEO Changes, Effective October 24, 2025Integer Holdings Corporation announced that Joseph Dziedzic will retire as Chief Executive Officer, effective October 24, 2025. At that time, Payman Khales, Chief Operating Officer, will assume the CEO position. To ensure a smooth transition, Mr. Dziedzic will serve as an advisor to the Company through March 31, 2026. Mr. Khales joined Integer in 2018 as President of the Cardio & Vascular business. Under his leadership, the business established a successful market/customer-based strategy, doubling sales in seven years, accelerating market penetration, and achieving above-market growth, while improving service levels and profitability. Since becoming COO, he has overseen both of Integer’s business units, Cardio & Vascular and Cardiac Rhythm Management & Neuromodulation, along with global operations and manufacturing strategy. Mr. Khales currently serves as COO of Integer, and previously served as President of the Cardio & Vascular product category since 2018. Prior to joining Integer, Mr. Khales served as President of the Environmental Technologies business segment for CECO Environmental Corp., a diversified global provider of engineered technologies to the environmental, energy, and fluid handling and filtration industrial segments. He also held several progressive leadership roles at Ingersoll Rand Company. Mr. Khales holds an Executive Master of Business Administration from Indiana University’s Kelley School of Business, and a Bachelor of Science in Mechanical Engineering from École Polytechnique de Montréal.분석 기사 • Apr 15These 4 Measures Indicate That Integer Holdings (NYSE:ITGR) Is Using Debt Reasonably WellLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Buy Or Sell Opportunity • Apr 08Now 23% undervalued after recent price dropOver the last 90 days, the stock has fallen 20% to US$107. The fair value is estimated to be US$138, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 15%. For the next 3 years, revenue is forecast to grow by 6.7% per annum. Earnings are also forecast to grow by 19% per annum over the same time period.분석 기사 • Apr 03Estimating The Intrinsic Value Of Integer Holdings Corporation (NYSE:ITGR)Key Insights Using the 2 Stage Free Cash Flow to Equity, Integer Holdings fair value estimate is US$143 Integer...공지 • Mar 27Integer Holdings Corporation to Report Q1, 2025 Results on Apr 24, 2025Integer Holdings Corporation announced that they will report Q1, 2025 results at 8:00 AM, Eastern Standard Time on Apr 24, 2025분석 기사 • Mar 20Integer Holdings (NYSE:ITGR) Hasn't Managed To Accelerate Its ReturnsIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...공지 • Mar 19Integer Holdings Corporation, Annual General Meeting, May 21, 2025Integer Holdings Corporation, Annual General Meeting, May 21, 2025. Location: 5830 granite parkway, suite 1150, plano, texas 75024, United StatesRecent Insider Transactions Derivative • Mar 14President exercised options and sold US$1.6m worth of stockOn the 11th of March, Joseph Dziedzic exercised options to acquire 13k shares at no cost and sold these for an average price of US$120 per share. This trade did not impact their existing holding. For the year to December 2018, Joseph's total compensation was 14% salary and 86% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since March 2024, Joseph's direct individual holding has increased from 222.32k shares to 291.78k. Company insiders have collectively sold US$9.7m more than they bought, via options and on-market transactions in the last 12 months.공지 • Feb 21+ 1 more updateInteger Holdings Corporation (NYSE:ITGR) signed a purchase agreement to acquire Vertical Solutions, Inc for $28 million.Integer Holdings Corporation (NYSE:ITGR) signed a purchase agreement to acquire Vertical Solutions, Inc. for $28 million on February 18, 2025. The consideration is payable $23 million in cash and $5 million in Integer common stock, subject to customary purchase price adjustments, offset by an expected $3 million NPV tax benefit. The expected completion of the transaction is by the end of February 2025.Reported Earnings • Feb 20Full year 2024 earnings: EPS misses analyst expectationsFull year 2024 results: EPS: US$3.60 (up from US$2.72 in FY 2023). Revenue: US$1.72b (up 7.5% from FY 2023). Net income: US$121.1m (up 34% from FY 2023). Profit margin: 7.1% (up from 5.7% in FY 2023). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 8.5%. Revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 7.9% growth forecast for the Medical Equipment industry in the US. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 17% per year.공지 • Feb 05Integer Holdings Corporation (NYSE:ITGR) acquired Substantially All Assets of Precision Coating Company, Inc. for approximately $150 million.Integer Holdings Corporation (NYSE:ITGR) acquired Substantially All Assets of Precision Coating Company, Inc. for approximately $150 million on January 7, 2025. A cash consideration of $152 million will be paid by Integer Holdings Corporation, subject to adjustment for additional contingent consideration. As part of consideration, $152 million is paid towards assets of Substantially All Assets of Precision Coating Company, Inc. Integer Holdings Corporation (NYSE:ITGR) completed the acquisition of Substantially All Assets of Precision Coating Company, Inc. on January 7, 2025. Piper Sandler Companies (NYSE:PIPR) acted as financial advisor to Precision Coating Company, Inc.분석 기사 • Jan 28What Is Integer Holdings Corporation's (NYSE:ITGR) Share Price Doing?Integer Holdings Corporation ( NYSE:ITGR ), is not the largest company out there, but it saw a double-digit share price...Recent Insider Transactions Derivative • Jan 24President exercised options and sold US$1.1m worth of stockOn the 21st of January, Joseph Dziedzic exercised options to acquire 8k shares at no cost and sold these for an average price of US$142 per share. This trade did not impact their existing holding. For the year to December 2018, Joseph's total compensation was 14% salary and 86% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since March 2024, Joseph's direct individual holding has increased from 222.32k shares to 224.21k. Company insiders have collectively sold US$8.1m more than they bought, via options and on-market transactions in the last 12 months.공지 • Jan 23Integer Holdings Corporation to Report Q4, 2024 Results on Feb 20, 2025Integer Holdings Corporation announced that they will report Q4, 2024 results at 8:00 AM, US Eastern Standard Time on Feb 20, 2025분석 기사 • Jan 14Here's Why Integer Holdings (NYSE:ITGR) Has Caught The Eye Of InvestorsThe excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...Recent Insider Transactions Derivative • Jan 07Key Executive exercised options and sold US$376k worth of stockOn the 3rd of January, John Harris exercised options to acquire 3k shares at no cost and sold these for an average price of US$134 per share. This trade did not impact their existing holding. Since March 2024, John's direct individual holding has increased from 1.47k shares to 1.52k. Company insiders have collectively sold US$7.5m more than they bought, via options and on-market transactions in the last 12 months.분석 기사 • Jan 01Integer Holdings Corporation's (NYSE:ITGR) Share Price Matching Investor OpinionInteger Holdings Corporation's ( NYSE:ITGR ) price-to-earnings (or "P/E") ratio of 38.2x might make it look like a...분석 기사 • Dec 04Returns On Capital At Integer Holdings (NYSE:ITGR) Have Hit The BrakesIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Reported Earnings • Oct 24Third quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behindThird quarter 2024 results: EPS: US$1.08 (up from US$0.82 in 3Q 2023). Revenue: US$431.4m (up 6.6% from 3Q 2023). Net income: US$36.3m (up 33% from 3Q 2023). Profit margin: 8.4% (up from 6.7% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 2.1%. Earnings per share (EPS) exceeded analyst estimates by 4.8%. Revenue is forecast to grow 6.6% p.a. on average during the next 3 years, compared to a 8.2% growth forecast for the Medical Equipment industry in the US. Over the last 3 years on average, earnings per share has increased by 9% per year whereas the company’s share price has increased by 11% per year.공지 • Oct 24+ 1 more updateInteger Holdings Corporation Revises Earnings Guidance for the Year 2024Integer Holdings Corporation revised earnings guidance for the year 2024. For the year, company expected sales growth of 10% to 11% with above-market organic sales growth of 7% to 8%. Sales expected to be in range of $1,707 Million to $1,727 Million. Operating income to be in range of $205 Million to $213 Million. Diluted earnings per share to be in range of $3.42 Million to $3.61 Million. Unless otherwise stated, 2024 Outlook and comparisons are presented on a continuing operations basis. Company have raised the midpoint of full year profit and EPS outlook, compared to the 2024 outlook from July, revised to exclude Electrochem.분석 기사 • Oct 18Integer Holdings (NYSE:ITGR) Has A Pretty Healthy Balance SheetLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...분석 기사 • Oct 05Is Now An Opportune Moment To Examine Integer Holdings Corporation (NYSE:ITGR)?Integer Holdings Corporation ( NYSE:ITGR ), is not the largest company out there, but it saw a decent share price...Seeking Alpha • Oct 02Integer Holdings: More Than Re-Rated HereSummary Integer Holdings shares have surged over 25% this year due to resilient organic growth and margin expansion, leaving current valuation multiples demanding. The company, a major medical device manufacturer, has shown solid growth, with revenues doubling over the past decade to $1.6 billion in 2023. Despite a solid performance, Integer's high valuation multiples and leverage make me cautious, as recent bolt-on deals haven't significantly impacted the investment thesis. With shares trading at 25 times earnings and premium expectations, I see no reason to chase the stock at all-time highs for long-term risk-reward. Read the full article on Seeking Alpha공지 • Sep 27Integer Holdings Corporation to Report Q3, 2024 Results on Oct 24, 2024Integer Holdings Corporation announced that they will report Q3, 2024 results at 8:00 AM, US Eastern Standard Time on Oct 24, 2024분석 기사 • Sep 22Here's Why Integer Holdings (NYSE:ITGR) Has Caught The Eye Of InvestorsInvestors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...새 내러티브 • Sep 02Expanding In High-Growth Markets With Calculated Acquisitions Boosts Revenue Potential Strong customer demand and operational improvements are poised to drive significant revenue growth and expand operating margins. 분석 기사 • Aug 28Here's What To Make Of Integer Holdings' (NYSE:ITGR) Decelerating Rates Of ReturnIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...분석 기사 • Aug 16What You Can Learn From Integer Holdings Corporation's (NYSE:ITGR) P/EWith a price-to-earnings (or "P/E") ratio of 38.4x Integer Holdings Corporation ( NYSE:ITGR ) may be sending very...Recent Insider Transactions • Aug 02Independent Director recently sold US$551k worth of stockOn the 31st of July, Jean Hobby sold around 5k shares on-market at roughly US$120 per share. This transaction amounted to 67% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth US$992k. Insiders have been net sellers, collectively disposing of US$2.9m more than they bought in the last 12 months.Recent Insider Transactions Derivative • Aug 01Key Executive notifies of intention to sell stockJohn Harris intends to sell 3k shares in the next 90 days after lodging an Intent To Sell Form on the 30th of July. If the sale is conducted around the recent share price of US$124, it would amount to US$421k. Since March 2024, John's direct individual holding has increased from 1.47k shares to 4.92k. Company insiders have collectively sold US$5.0m more than they bought, via options and on-market transactions in the last 12 months.분석 기사 • Jul 28Estimating The Fair Value Of Integer Holdings Corporation (NYSE:ITGR)Key Insights The projected fair value for Integer Holdings is US$120 based on 2 Stage Free Cash Flow to Equity Current...Reported Earnings • Jul 26Second quarter 2024 earnings: EPS exceeds analyst expectationsSecond quarter 2024 results: EPS: US$0.93 (up from US$0.72 in 2Q 2023). Revenue: US$436.2m (up 9.0% from 2Q 2023). Net income: US$31.2m (up 30% from 2Q 2023). Profit margin: 7.2% (up from 6.0% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 3.8%. Revenue is forecast to grow 6.8% p.a. on average during the next 3 years, compared to a 8.3% growth forecast for the Medical Equipment industry in the US. Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has increased by 6% per year.공지 • Jul 26Integer Holdings Corporation Provides Earnings Guidance for the Year 2024Integer Holdings Corporation provided earnings guidance for the year 2024. For the year, the company expects sales in the range of $1,735 million to $1,770 million, Operating income in the range of $202 million to $220 million, Net income in the range of $116 million to $130 million, Diluted earnings per share in the range of $3.26 to $3.67.분석 기사 • Jul 12Is Integer Holdings (NYSE:ITGR) Using Too Much Debt?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...이익 및 매출 성장 예측NYSE:ITGR - 애널리스트 향후 추정치 및 과거 재무 데이터 (USD Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/20282,026160N/AN/A312/31/20271,925157168284812/31/20261,81711310425494/3/20261,856142100190N/A12/31/20251,854103105196N/A9/26/20251,83187121204N/A6/27/20251,79584120210N/A3/28/20251,74678112213N/A12/31/20241,717121100205N/A9/27/20241,67211574198N/A6/28/20241,63710766188N/A3/29/20241,5859773197N/A12/31/20231,5568960180N/A9/29/20231,5247962176N/A6/30/20231,4696732142N/A3/31/20231,4446716104N/A12/31/20221,3316042116N/A9/30/20221,3176837104N/A7/1/20221,2807467125N/A4/1/20221,2428382138N/A12/31/20211,22193103157N/A10/1/20211,17788147189N/A7/2/20211,10797133172N/A4/2/20211,03568145185N/A12/31/20201,07377130181N/A10/2/20201,13073100164N/A7/3/20201,19873112176N/A4/3/20201,272101127187N/A12/31/20191,25891N/A165N/A9/27/20191,23599N/A159N/A6/28/20191,23760N/A168N/A3/29/20191,23755N/A132N/A12/28/20181,21547N/A167N/A9/28/20181,21483N/A155N/A6/29/20181,195111N/A139N/A3/30/20181,16297N/A157N/A12/29/20171,13687N/A149N/A9/29/20171,19340N/A149N/A6/30/20171,25432N/A149N/A3/31/20171,32122N/A114N/A12/30/20161,07625N/A106N/A9/30/20161,345-27N/A53N/A7/1/20161,145-38N/A24N/A4/1/2016971-28N/A35N/A1/1/2016800-8N/A12N/A10/2/201565331N/A58N/A7/3/201567845N/A77N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: ITGR 의 연간 예상 수익 증가율(7.1%)이 saving rate(3.5%)보다 높습니다.수익 vs 시장: ITGR 의 연간 수익(7.1%)이 US 시장(16.4%)보다 느리게 성장할 것으로 예상됩니다.고성장 수익: ITGR 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.수익 대 시장: ITGR 의 수익(연간 3.8%)이 US 시장(연간 11.4%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: ITGR 의 수익(연간 3.8%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: ITGR의 자본 수익률은 3년 후 12.2%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YHealthcare 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/07 11:32종가2026/05/07 00:00수익2026/04/03연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Integer Holdings Corporation는 17명의 분석가가 다루고 있습니다. 이 중 9명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Jasper HellwegArgus Research CompanyRobert WassermanBenchmark CompanyTravis SteedBofA Global Research14명의 분석가 더 보기
공지 • May 03Integer Holdings Corporation Announces Earnings Guidance for the Year 2026Integer Holdings Corporation announced earnings guidance for the year 2026. For the year, the company expects as reported sales in the range of $1,805 million to $1,835 million decrease of 3% to 1% as compared to previous year, operating income in the range of $165 million to $185 million decrease of 25% to 16% as compared to previous year, net income in the range of $105 million to $125 million increase of 2% to 21% as compared to previous year, and diluted earnings per share in the range of $3.07 to $3.64 increase of 6% to 26% as compared to previous year.
Price Target Changed • Feb 22Price target increased by 7.4% to US$91.88Up from US$85.57, the current price target is an average from 8 analysts. New target price is 8.3% above last closing price of US$84.85. Stock is down 35% over the past year. The company is forecast to post earnings per share of US$4.19 for next year compared to US$2.96 last year.
공지 • Feb 19Integer Holdings Corporation Provides Earnings Guidance for the Year 2026Integer Holdings Corporation provided earnings guidance for the year 2026. For the year, the company expects as reported sales in the range of $1,826 million to $1,876 million, operating income in the range of $184 million to $204 million, net income in the range of $121 million to $138 million, and diluted earnings per share in the range of $3.53 to $4.01.
Price Target Changed • Oct 24Price target decreased by 38% to US$86.00Down from US$139, the current price target is an average from 7 analysts. New target price is 18% above last closing price of US$72.91. Stock is down 42% over the past year. The company is forecast to post earnings per share of US$2.80 for next year compared to US$3.60 last year.
공지 • Oct 23+ 1 more updateInteger Holdings Corporation Provides Earnings Guidance for the Year 2026 and Year 2027Integer Holdings Corporation provided earnings guidance for the year 2026 and year 2027. For the year 2026, the company expects Reported sales to be down 2% to up 2% and Organic sales to be flat to up 4%. For the year 2027, the company expects growth 200 basis points above market.
공지 • Apr 25Integer Holdings Corporation Provides Earnings Guidance for the Year 2025Integer Holdings Corporation provided earnings guidance for the year 2025. For the year, the company expects sales in the range of $1,846 million to $1,880 million, Operating income in the range of $242 million to $258 million, Income from continuing operations of $108 million to $120 million, Diluted earnings per share in the range of $3.00 to $3.36.
실시간 뉴스 • May 05Integer Holdings Considers Sale or Merger Following Q1 Profit and Lowered 2026 OutlookInteger reported income from continuing operations of $16.5 million in Q1 2026, compared with a prior-year loss of $22.5 million, alongside modest sales growth. The board has launched a broad review of options including a potential sale, merger or business combination, supported by Goldman Sachs and Davis Polk & Wardwell. Q1 2026 revenue and adjusted EPS were ahead of market expectations, but full-year 2026 revenue guidance was cut to about $1.82b and adjusted EPS guidance was lowered due to product rollout issues and revised customer demand. For you as an investor, the key tension is between improved quarterly profitability and the more cautious outlook for the rest of 2026. Management pointed to three new product rollouts and updated customer demand forecasts as the main reasons for trimming guidance, along with a weaker operating margin compared with last year. The company also expects reported sales to be slightly lower for 2026, with organic sales flat to down 1%, tied to temporary normalization in the electrophysiology market rather than contract losses or supply changes. At the same time, the board’s decision to review “all potential opportunities” reflects external interest in the business and a willingness to consider structural changes. This process can introduce uncertainty around execution, stock price volatility and potential impacts on the balance sheet, and there is no timeline or assurance that a transaction will occur. Investors may want to watch for updates on the review, further commentary on the electrophysiology market, and progress on integrating the three tuck-in acquisitions completed since early 2025.
공지 • May 03Integer Holdings Corporation Announces Earnings Guidance for the Year 2026Integer Holdings Corporation announced earnings guidance for the year 2026. For the year, the company expects as reported sales in the range of $1,805 million to $1,835 million decrease of 3% to 1% as compared to previous year, operating income in the range of $165 million to $185 million decrease of 25% to 16% as compared to previous year, net income in the range of $105 million to $125 million increase of 2% to 21% as compared to previous year, and diluted earnings per share in the range of $3.07 to $3.64 increase of 6% to 26% as compared to previous year.
Reported Earnings • May 01First quarter 2026 earnings: Revenues exceed analysts expectations while EPS lags behindFirst quarter 2026 results: EPS: US$0.48 (up from US$0.66 loss in 1Q 2025). Revenue: US$439.6m (flat on 1Q 2025). Net income: US$16.5m (up US$39.0m from 1Q 2025). Profit margin: 3.8% (up from net loss in 1Q 2025). Revenue exceeded analyst estimates by 3.2%. Earnings per share (EPS) missed analyst estimates by 26%. Revenue is forecast to grow 3.8% p.a. on average during the next 3 years, compared to a 7.9% growth forecast for the Medical Equipment industry in the US. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
내러티브 업데이트 • Apr 20ITGR: Fair View Expects 2026 Product Drag To Fade As Pipeline BuildsAnalysts have lifted their price targets on Integer Holdings to a range of about $92 to $101, reflecting updated views on the timing of headwinds from underperforming products and the potential contribution from new products after 2026. Analyst Commentary Recent price target revisions cluster in a range of about $92 to $101, which signals that analysts see room for upside but also recognize execution questions around product transitions and growth consistency.
공지 • Apr 08Integer Holdings Corporation, Annual General Meeting, May 20, 2026Integer Holdings Corporation, Annual General Meeting, May 20, 2026. Location: hilton dallas/plano granite park hotel, 5805 granite parkway, plano, plano United States
공지 • Apr 07Integer Holdings Corporation Announces Pamela G. Bailey, Independent Chair of the Board Will Not Stand for Re-Election At 2026 AGMInteger Holdings Corporation announced Pamela G. Bailey, who currently serves as Integer’s independent Chair of the Board, will not stand for re-election at the Company’s 2026 Annual Meeting of Stockholders, scheduled for May 20, 2026.
내러티브 업데이트 • Apr 05ITGR: Fair View Sees 2026 Headwinds Easing As Newer Products Gain TractionAnalysts have raised Integer Holdings' implied price target range to about $92 to $101. This reflects updated views that near term product headwinds could ease by 2026, supported by contributions from newer products.
공지 • Apr 02Integer Holdings Corporation to Report Q1, 2026 Results on Apr 30, 2026Integer Holdings Corporation announced that they will report Q1, 2026 results Pre-Market on Apr 30, 2026
내러티브 업데이트 • Mar 20ITGR: Fair View Sees 2026 Product Headwinds Easing As Recovery ProgressesAnalysts have nudged their price expectations for Integer Holdings higher, with the updated fair value moving from $92.63 to $93.25 as they factor in recent target increases and ongoing work to address product headwinds and potential future growth drivers. Analyst Commentary Bullish Takeaways Bullish analysts see the higher price targets, now clustered in the low to low triple digits, as recognition that recent headwinds are already reflected in expectations and that current valuation assumes a measured recovery path.
공지 • Mar 12Integer Holdings Corporation Announces Board Changes, Effective March 12, 2026Integer Holdings Corporation has appointed two new directors to its Board of Directors: James F. Flanagan and Aaron Kapito. These appointments are effective as of March 12, 2026, and the board size has been increased to 13 members. The Cooperation Agreement also stipulates that two incumbent directors will not stand for re-election at the 2026 Annual Meeting of Stockholders. The agreement includes provisions for the appointment of the new directors to specific board committees, including the Audit Committee, the Compensation and Organization Committee, and the Technology Strategy Committee. The Cooperation Agreement includes voting commitments, standstill restrictions, and mutual non-disparagement provisions, which remain in place until the earlier of 30 days prior to the advance notice deadline for the 2027 Annual Meeting or one year from the effective date of the agreement. Mr. Flanagan is the former Chief Operating Officer of PwC from 2014 to 2021, bringing proven diversified, strategic, operational and qualified financial expertise through 39 years of increasing client and management roles. Previously, he also served as PwC’s US Financial Services Practice Leader from 2006 to 2014, and prior to that as the Transaction Services Leader from 2001 to 2006 and Transaction Services Partner from 1994 to 2001. He has served on the Board of Directors at Belami Ecommerce, a subsidiary of SkyX Platforms Corp. from 2022 to 2025, while also serving as Audit Committee Chair. Mr. Flanagan received a B.S. in Accounting from the C.W. Post School of Professional Accountancy at Long Island University. Mr. Kapito is a Partner at Politan Capital Management L.P., an investment management firm that he co-founded in 2021. Previously, Mr. Kapito served as a Senior Analyst at Lion Point Capital from 2018 to 2021, a Senior Analyst and founding member of Delonix Capital from 2016 to 2017, and an Associate Portfolio Manager for Elliott Management L.P. from 2011 to 2016. Mr. Kapito currently serves on the boards of Rocky Mountain Steel Mills, a manufacturer of high-performance steel products, and Associated Veterinary Partners, a veterinary clinic platform. Mr. Kapito received a B.S. in Economics from the Wharton School at the University of Pennsylvania and an M.B.A. from Harvard Business School.
내러티브 업데이트 • Mar 06ITGR: Fair View Balances 2026 Product Headwinds And New Launch RecoveryNarrative Update Analysts have lifted their blended price target on Integer Holdings to $92.63 from $85.57, citing updated views on future P/E, revenue growth headwinds tied to a few underperforming products and an eventual recovery supported by new product contributions. Analyst Commentary Recent research has focused on how Integer balances valuation against execution risks tied to specific product headwinds and future growth ambitions.
Recent Insider Transactions Derivative • Mar 03CEO, President & Director exercised options and sold US$1.5m worth of stockOn the 24th of February, Payman Khales exercised options to acquire 17k shares at no cost and sold these for an average price of US$87.10 per share. This trade did not impact their existing holding. For the year to December 2019, Payman's total compensation was 28% salary and 72% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since March 2025, Payman's direct individual holding has increased from 19.74k shares to 25.47k. Company insiders have collectively sold US$13m more than they bought, via options and on-market transactions in the last 12 months.
New Risk • Feb 22New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 42% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (17% operating cash flow to total debt). Minor Risk Large one-off items impacting financial results.
Price Target Changed • Feb 22Price target increased by 7.4% to US$91.88Up from US$85.57, the current price target is an average from 8 analysts. New target price is 8.3% above last closing price of US$84.85. Stock is down 35% over the past year. The company is forecast to post earnings per share of US$4.19 for next year compared to US$2.96 last year.
Reported Earnings • Feb 20Full year 2025 earnings: EPS exceeds analyst expectationsFull year 2025 results: EPS: US$2.96 (down from US$3.60 in FY 2024). Revenue: US$1.85b (up 8.0% from FY 2024). Net income: US$102.8m (down 15% from FY 2024). Profit margin: 5.5% (down from 7.1% in FY 2024). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 3.3%. Revenue is forecast to grow 4.1% p.a. on average during the next 3 years, compared to a 7.8% growth forecast for the Medical Equipment industry in the US. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.
내러티브 업데이트 • Feb 19ITGR: Fair Value Holds As FY26 Reacceleration Faces Confidence RebuildAnalysts have trimmed their price target on Integer Holdings to $86 from $88, citing expectations that it may take a few quarters before investors gain confidence in a potential reacceleration discussed for the second half of FY26. Analyst Commentary Recent research reflects a slightly more cautious stance on Integer Holdings, with the price target adjusted to $86 from $88.
공지 • Feb 19Integer Holdings Corporation Provides Earnings Guidance for the Year 2026Integer Holdings Corporation provided earnings guidance for the year 2026. For the year, the company expects as reported sales in the range of $1,826 million to $1,876 million, operating income in the range of $184 million to $204 million, net income in the range of $121 million to $138 million, and diluted earnings per share in the range of $3.53 to $4.01.
내러티브 업데이트 • Feb 05ITGR: Fair Value Holds As 2026 Reacceleration Awaits Coatings Asset IntegrationAnalysts reduced their price target for Integer Holdings to US$86 from US$88, citing expectations that it may take a few quarters before investors are comfortable underwriting a potential re acceleration in the second half of FY26. Analyst Commentary Bullish Takeaways Bullish analysts maintain a positive stance on the shares, suggesting they still see support for the current valuation even with a slightly lower price target.
Seeking Alpha • Feb 04Integer Holdings: Poor Uptake Of Certain Products Adversely Affecting StockSummary Integer Holdings is maintained at 'Hold' due to deteriorating fundamentals and bearish technical trends. Integer's Q3 earnings beat expectations, but a surprise guidance cut for 2026 triggered a sharp sell-off. Reduced 2026 sales outlook, driven by poor uptake of key products, has shaken investor confidence in future demand. Management's cost-cutting supports near-term profitability, but the market remains wary pending Q4 results and an updated outlook. Read the full article on Seeking Alpha
공지 • Jan 28Integer Holdings Corporation to Highlight Integrated R&D Solutions and Expanded Coating Capabilities During Md&M West 2026Integer Holdings Corporation will exhibit during MD&M West 2026 in Anaheim, Calif., Feb. 3 - 5. Integer will unveil a significantly expanded 20 x 50 sq. ft. new booth #3201, showcasing the company's full range of customer solutions. On prominent display will be R&D Velocity, Integer's integrated R&D ecosystem connecting design, prototyping and manufacturing to help medical device companies develop products that are manufacturable from the start, accelerating the time between design and manufacturability. The company will showcase several solutions - delivered through a network of locations globally - that are central to R&D Velocity, including: Differentiated Technology Platforms: Proven product technologies that enable, accelerate and de-risk the development of customers' next generation devices. Global Capabilities and Expertise: Specialized labs and integrated manufacturing all in one ecosystem along with dedicated engineers and global centers of excellence to accelerate every phase of development. Ease of Manufacturability: Designs optimized early to scale seamlessly, reducing rework and accelerating launch. Rapid Prototyping: Engineer-to-engineer collaboration delivering prototypes in as little as two weeks. Integer will additionally highlight a range of key product areas and innovations during MD&M West, including: Integer Medical Coatings: The company continues to expand its role as a fully integrated coating partner for medical devices, strengthening its ability to deliver end-to-end surface-modification solutions. Integer will also showcase its full coatings portfolio, including PTFE, PTFE alternatives, hydrophilic coatings, parylene, and advanced surface-modification technologies. Following the acquisitions of Precision Coating,VSi Parylene, and certain Biocoat assets last year, Integer has further strengthened its position as a fully integrated coating partner For medical devices. Cardiac Rhythm Management and Neuromodulation: Miniaturized technologies for finished IPG systems, as well as Gen 3 Li-Ion and Gen 2 CFx batteries. Cardio and Vascular: A full range of electrophysiology, structural heart, and neurovascular product solutions including complex catheters, guidewires, steerable introducers and sheaths, therapy delivery systems and implant technologies.
공지 • Jan 22Integer Holdings Corporation to Report Q4, 2025 Results on Feb 19, 2026Integer Holdings Corporation announced that they will report Q4, 2025 results Pre-Market on Feb 19, 2026
내러티브 업데이트 • Jan 21ITGR: Fair Value Suggests Recovery As 2026 Demand Visibility Gradually ImprovesAnalysts have modestly trimmed their blended price target for Integer Holdings to about $86, down from prior targets clustered closer to $88 and above. This reflects caution around the company's softer 2026 outlook and reduced visibility on the timing of any potential demand recovery.
내러티브 업데이트 • Jan 07ITGR: Fair Value Suggests Shares Will Recover As 2026 Visibility ImprovesAnalysts have inched their fair value estimate for Integer Holdings higher to about US$85.57 from roughly US$84.29, reflecting lower assumed discount rates and a slightly higher future P/E multiple. This follows recent research updates that cut price targets and ratings but still highlight the potential for recovery once revenue visibility improves.
내러티브 업데이트 • Dec 17ITGR: Shares Will Recover As 2026 Demand Visibility And Orders Gradually StabilizeThe analyst price target for Integer Holdings has been trimmed modestly, with analysts citing reduced 2026 visibility, order and demand headwinds across several newer product launches, and a longer wait for growth reacceleration as reasons for resetting expectations, even as they see the recent share price pullback as overdone. Analyst Commentary Bullish analysts acknowledge the near term reset to expectations but argue that the recent compression in Integer Holdings valuation already discounts a prolonged period of slower growth and execution risk.
공지 • Dec 11Saxena White P.A. Files Securities Fraud Class Action Against Integer Holdings Corporation and Certain of its ExecutivesSaxena White P.A. has filed a securities fraud class action lawsuit (the “Class Action”) in the United States District Court for the Southern District of New York against Integer Holdings Corporation (“Integer” or the “Company”) and certain of its executive officers (collectively, “Defendants”). The Class Action asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and U.S. Securities and Exchange Commission (“SEC”) Rule 10b-5 promulgated thereunder on behalf of all persons or entities that purchased Integer common stock between July 25, 2024 and October 22, 2025, inclusive (the “Class Period”), and were damaged thereby (the “Class”). The Class Action filed by Saxena White is captioned West Palm Beach Firefighters’ Pension Fund v. Integer Holdings Corporation, et al., No. 25-cv-10251 (S.D.N.Y.).Based in Plano, Texas, Integer purports to be one of the medical device contract development and manufacturing organizations in the world. The Company contracts with medical device companies to manufacture cardiac rhythm management and cardio and vascular (“C&V”) medical devices. Integer’s C&V product line generates approximately 60% of the Company’s total revenue. As a part of the C&V product line, Integer manufactures electrophysiology (“EP”) devices, which diagnose and map the heart’s electrical activity to address problems such as irregular heartbeats (cardiac arrhythmias).Prior to the Class Period, EP devices underwent a technological revolution as Integer customers began to develop devices for pulse field ablation (“PFA”) procedures that use brief, high-energy electrical pulses to treat atrial fibrillation. In turn, the industry became increasingly focused on integrating EP devices and PFA platforms to effectuate a more seamless cardiac procedure. As a result, EP devices represented a significant growth driver for Integer’s C&V segment. Leading up to the Class Period, CEO Dziedzic described PFA platforms as “a tailwind” due to the Company’s “vertically integrated offering[,]” while also touting that Integer “benefit[ed] significantly from electrophysiology procedure growth.” CEO Dziedzic further explained, “We participate in the full procedure, which is one of the strengths of Integer.” The Class Action alleges that, during the Class Period, Defendants made materially false and/or misleading statements and failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose that: (1) Integer materially overstated its competitive position within the growing EP manufacturing market; (2) despite Integer’s claims of strong visibility into customer demand, the Company was experiencing a sustained deterioration in sales relating to two of its EP devices; (3) in turn, Integer mischaracterized its EP devices as a long-term growth driver for the Company’s C&V segment; (4) as a result of the above, Defendants’ positive statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
내러티브 업데이트 • Dec 03ITGR: Shares Will Recover As 2026 Demand Visibility Gradually ImprovesAnalysts have trimmed their price target on Integer Holdings slightly, to about $84.57 from roughly $84.86, as they factor in softer near term visibility and delayed confidence in a second half 2026 re acceleration, despite longer term optimism about the company’s recovery and customer relationships. Analyst Commentary Street research following Integer Holdings recent update reflects a sharply reset near term outlook, but also a degree of longer term confidence in the company’s strategic positioning and customer relationships.
내러티브 업데이트 • Nov 19ITGR: Shares Will Recover As Order Headwinds Are ResolvedInteger Holdings' average analyst price target has sharply decreased, dropping from above $120 to a range of $77 to $88. Analysts cite concerns that recent order shifts, lowered guidance, and uncertainty in the 2026 outlook justify a reset in valuation expectations for the stock.
분석 기사 • Nov 06What You Can Learn From Integer Holdings Corporation's (NYSE:ITGR) P/E After Its 35% Share Price CrashInteger Holdings Corporation ( NYSE:ITGR ) shareholders that were waiting for something to happen have been dealt a...
분석 기사 • Nov 05Some May Be Optimistic About Integer Holdings' (NYSE:ITGR) EarningsThe most recent earnings report from Integer Holdings Corporation ( NYSE:ITGR ) was disappointing for shareholders...
공지 • Nov 05Integer Holdings Corporation (NYSE:ITGR) announces an Equity Buyback for $200 million worth of its shares.Integer Holdings Corporation (NYSE:ITGR) announces a share repurchase program. Under the program, the company will repurchase up to $200 million worth of its common stock. The company intends to primarily utilize cash on hand and free cash flows to fund the share repurchase program. The program has no expiration date.
내러티브 업데이트 • Nov 05ITGR: Shares Will Recover As Demand Normalizes And Inventory Pressures EaseInteger Holdings’ analyst price target has been revised significantly lower, dropping from approximately $137 to $85 per share. Analysts cite headwinds from reduced revenue growth expectations and a weaker 2026 outlook following order changes to three key products.
Buy Or Sell Opportunity • Oct 30Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 41% to US$63.32. The fair value is estimated to be US$80.00, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 13%. Revenue is forecast to grow by 5.6% in 2 years. Earnings are forecast to grow by 106% in the next 2 years.
Reported Earnings • Oct 24Third quarter 2025 earnings: EPS misses analyst expectationsThird quarter 2025 results: EPS: US$1.13 (up from US$1.08 in 3Q 2024). Revenue: US$467.7m (up 8.4% from 3Q 2024). Net income: US$39.7m (up 9.4% from 3Q 2024). Profit margin: 8.5% (up from 8.4% in 3Q 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 7.0%. Revenue is forecast to grow 3.8% p.a. on average during the next 3 years, compared to a 8.4% growth forecast for the Medical Equipment industry in the US. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.
Price Target Changed • Oct 24Price target decreased by 38% to US$86.00Down from US$139, the current price target is an average from 7 analysts. New target price is 18% above last closing price of US$72.91. Stock is down 42% over the past year. The company is forecast to post earnings per share of US$2.80 for next year compared to US$3.60 last year.
공지 • Oct 24+ 1 more updateInteger Holdings Corporation Announces CEO Changes, Effective October 24, 2025Integer Holdings Corporation appointed Payman Khales as Chief Executive Officer, effective October 24, 2025. He succeeds Joseph Dziedzic, who is retiring after eight years of distinguished service as Integer President and CEO and will continue to serve as an advisor through March 31, 2026, to support a smooth transition. Mr. Khales joined Integer in 2018 as President of the Cardio & Vascular business, where he led a successful market- and customer-focused strategy, doubling sales in seven years and driving above-market growth, while further improving service levels and profitability. Most recently, as Chief Operating Officer, he oversaw both of Integer's business units and its global operations, further strengthening Integer's reputation as a strategic partner to medical device companies and OEMs worldwide. Prior to joining Integer, Mr. Khales held senior leadership roles at CECO Environmental Corp. and Ingersoll Rand Company. He holds an Executive MBA from Indiana University's Kelley School of Business and a Bachelor of Science in Mechanical Engineering from cole Polytechnique de Montréal. As previously disclosed, also effective October 24, 2025, Mr. Dziedzic will serve as a Special Advisor for the Company until March 31, 2026, to assist Mr. Khales with transition matters.
공지 • Oct 23+ 1 more updateInteger Holdings Corporation Provides Earnings Guidance for the Year 2026 and Year 2027Integer Holdings Corporation provided earnings guidance for the year 2026 and year 2027. For the year 2026, the company expects Reported sales to be down 2% to up 2% and Organic sales to be flat to up 4%. For the year 2027, the company expects growth 200 basis points above market.
내러티브 업데이트 • Oct 22Analysts Lower Integer Holdings Price Target Amid Cautious Sector Outlook and Stable Growth ProjectionsAnalysts have lowered their price target for Integer Holdings from $137.00 to $121.00, citing market volatility concerns and a cautious outlook for new investment within the MedTech sector, even as expectations remain for healthy quarterly performance. Analyst Commentary Recent analyst notes provide a balanced view of Integer Holdings, with both optimism and caution expressed regarding the company’s outlook and sector dynamics.
공지 • Sep 25Integer Holdings Corporation to Report Q3, 2025 Results on Oct 23, 2025Integer Holdings Corporation announced that they will report Q3, 2025 results Pre-Market on Oct 23, 2025
분석 기사 • Sep 09Is It Too Late To Consider Buying Integer Holdings Corporation (NYSE:ITGR)?While Integer Holdings Corporation ( NYSE:ITGR ) might not have the largest market cap around , it received a lot of...
분석 기사 • Aug 12What You Can Learn From Integer Holdings Corporation's (NYSE:ITGR) P/EWith a price-to-earnings (or "P/E") ratio of 44.1x Integer Holdings Corporation ( NYSE:ITGR ) may be sending very...
분석 기사 • Jul 22We Think Integer Holdings (NYSE:ITGR) Can Stay On Top Of Its DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
공지 • Jul 11Integer Holdings Corporation Appoints Michael Coyle to Board of DirectorsInteger Holdings Corporation announced it has appointed Michael Coyle to its Board of Directors. Coyle brings more than 40 years of leadership in the medical device industry to Integer and joins the Board as a member of the Audit Committee, Compensation & Organization Committee, and Technology Strategy Committee. He most recently served as president and CEO of iRhythm Technologies. Before that, he was executive vice president and group president of Medtronic’s cardio and vascular group and held leadership roles at St. Jude Medical and Eli Lilly earlier in his career. Coyle is currently a director on the Haemonetics Corporation and BaroPace boards and previously held positions on the boards of VNUS Medical Technologies Inc. and Volcano Corporation. He earned a master's degree in business administration from the Wharton School of Business, University of Pennsylvania, and a bachelor's degree from Case Western Reserve University. He additionally holds six U.S. patents related to cardiovascular medical device products and technologies.
분석 기사 • Jul 08Integer Holdings Corporation (NYSE:ITGR) Shares Could Be 30% Below Their Intrinsic Value EstimateKey Insights Integer Holdings' estimated fair value is US$167 based on 2 Stage Free Cash Flow to Equity Integer...
공지 • Jun 30+ 5 more updatesInteger Holdings Corporation(NYSE:ITGR) dropped from Russell 3000 Value IndexInteger Holdings Corporation(NYSE:ITGR) dropped from Russell 3000 Value Index
공지 • Jun 26Integer Holdings Corporation to Report Q2, 2025 Results on Jul 24, 2025Integer Holdings Corporation announced that they will report Q2, 2025 results at 8:00 AM, US Eastern Standard Time on Jul 24, 2025
분석 기사 • Jun 25Returns On Capital At Integer Holdings (NYSE:ITGR) Have StalledTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'll want to...
Recent Insider Transactions Derivative • Jun 05Independent Director notifies of intention to sell stockDonald Spence intends to sell 15k shares in the next 90 days after lodging an Intent To Sell Form on the 4th of June. If the sale is conducted around the recent share price of US$120, it would amount to US$1.8m. Since March 2025, Donald has owned 18.78k shares directly. Company insiders have collectively sold US$12m more than they bought, via options and on-market transactions in the last 12 months.
Buy Or Sell Opportunity • May 28Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 3.6% to US$119. The fair value is estimated to be US$151, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 15%. Revenue is forecast to grow by 17% in 2 years. Earnings are forecast to grow by 166% in the next 2 years.
분석 기사 • May 25Is Now The Time To Look At Buying Integer Holdings Corporation (NYSE:ITGR)?Integer Holdings Corporation ( NYSE:ITGR ), might not be a large cap stock, but it saw a double-digit share price rise...
분석 기사 • May 02Some May Be Optimistic About Integer Holdings' (NYSE:ITGR) EarningsShareholders appeared unconcerned with Integer Holdings Corporation's ( NYSE:ITGR ) lackluster earnings report last...
Buy Or Sell Opportunity • Apr 30Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 12% to US$126. The fair value is estimated to be US$158, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 15%. Revenue is forecast to grow by 17% in 2 years. Earnings are forecast to grow by 166% in the next 2 years.
New Risk • Apr 27New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 36% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (17% operating cash flow to total debt). Minor Risk Large one-off items impacting financial results.
Reported Earnings • Apr 25First quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behindFirst quarter 2025 results: US$0.66 loss per share (down from US$0.61 profit in 1Q 2024). Revenue: US$437.4m (up 5.4% from 1Q 2024). Net loss: US$22.5m (down 210% from profit in 1Q 2024). Revenue exceeded analyst estimates by 2.0%. Earnings per share (EPS) missed analyst estimates. Revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 7.9% growth forecast for the Medical Equipment industry in the US. Over the last 3 years on average, earnings per share has increased by 16% per year whereas the company’s share price has increased by 18% per year.
공지 • Apr 25Integer Holdings Corporation Provides Earnings Guidance for the Year 2025Integer Holdings Corporation provided earnings guidance for the year 2025. For the year, the company expects sales in the range of $1,846 million to $1,880 million, Operating income in the range of $242 million to $258 million, Income from continuing operations of $108 million to $120 million, Diluted earnings per share in the range of $3.00 to $3.36.
공지 • Apr 24+ 1 more updateInteger Holdings Corporation Announces CEO Changes, Effective October 24, 2025Integer Holdings Corporation announced that Joseph Dziedzic will retire as Chief Executive Officer, effective October 24, 2025. At that time, Payman Khales, Chief Operating Officer, will assume the CEO position. To ensure a smooth transition, Mr. Dziedzic will serve as an advisor to the Company through March 31, 2026. Mr. Khales joined Integer in 2018 as President of the Cardio & Vascular business. Under his leadership, the business established a successful market/customer-based strategy, doubling sales in seven years, accelerating market penetration, and achieving above-market growth, while improving service levels and profitability. Since becoming COO, he has overseen both of Integer’s business units, Cardio & Vascular and Cardiac Rhythm Management & Neuromodulation, along with global operations and manufacturing strategy. Mr. Khales currently serves as COO of Integer, and previously served as President of the Cardio & Vascular product category since 2018. Prior to joining Integer, Mr. Khales served as President of the Environmental Technologies business segment for CECO Environmental Corp., a diversified global provider of engineered technologies to the environmental, energy, and fluid handling and filtration industrial segments. He also held several progressive leadership roles at Ingersoll Rand Company. Mr. Khales holds an Executive Master of Business Administration from Indiana University’s Kelley School of Business, and a Bachelor of Science in Mechanical Engineering from École Polytechnique de Montréal.
분석 기사 • Apr 15These 4 Measures Indicate That Integer Holdings (NYSE:ITGR) Is Using Debt Reasonably WellLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Buy Or Sell Opportunity • Apr 08Now 23% undervalued after recent price dropOver the last 90 days, the stock has fallen 20% to US$107. The fair value is estimated to be US$138, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 15%. For the next 3 years, revenue is forecast to grow by 6.7% per annum. Earnings are also forecast to grow by 19% per annum over the same time period.
분석 기사 • Apr 03Estimating The Intrinsic Value Of Integer Holdings Corporation (NYSE:ITGR)Key Insights Using the 2 Stage Free Cash Flow to Equity, Integer Holdings fair value estimate is US$143 Integer...
공지 • Mar 27Integer Holdings Corporation to Report Q1, 2025 Results on Apr 24, 2025Integer Holdings Corporation announced that they will report Q1, 2025 results at 8:00 AM, Eastern Standard Time on Apr 24, 2025
분석 기사 • Mar 20Integer Holdings (NYSE:ITGR) Hasn't Managed To Accelerate Its ReturnsIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...
공지 • Mar 19Integer Holdings Corporation, Annual General Meeting, May 21, 2025Integer Holdings Corporation, Annual General Meeting, May 21, 2025. Location: 5830 granite parkway, suite 1150, plano, texas 75024, United States
Recent Insider Transactions Derivative • Mar 14President exercised options and sold US$1.6m worth of stockOn the 11th of March, Joseph Dziedzic exercised options to acquire 13k shares at no cost and sold these for an average price of US$120 per share. This trade did not impact their existing holding. For the year to December 2018, Joseph's total compensation was 14% salary and 86% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since March 2024, Joseph's direct individual holding has increased from 222.32k shares to 291.78k. Company insiders have collectively sold US$9.7m more than they bought, via options and on-market transactions in the last 12 months.
공지 • Feb 21+ 1 more updateInteger Holdings Corporation (NYSE:ITGR) signed a purchase agreement to acquire Vertical Solutions, Inc for $28 million.Integer Holdings Corporation (NYSE:ITGR) signed a purchase agreement to acquire Vertical Solutions, Inc. for $28 million on February 18, 2025. The consideration is payable $23 million in cash and $5 million in Integer common stock, subject to customary purchase price adjustments, offset by an expected $3 million NPV tax benefit. The expected completion of the transaction is by the end of February 2025.
Reported Earnings • Feb 20Full year 2024 earnings: EPS misses analyst expectationsFull year 2024 results: EPS: US$3.60 (up from US$2.72 in FY 2023). Revenue: US$1.72b (up 7.5% from FY 2023). Net income: US$121.1m (up 34% from FY 2023). Profit margin: 7.1% (up from 5.7% in FY 2023). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 8.5%. Revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 7.9% growth forecast for the Medical Equipment industry in the US. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 17% per year.
공지 • Feb 05Integer Holdings Corporation (NYSE:ITGR) acquired Substantially All Assets of Precision Coating Company, Inc. for approximately $150 million.Integer Holdings Corporation (NYSE:ITGR) acquired Substantially All Assets of Precision Coating Company, Inc. for approximately $150 million on January 7, 2025. A cash consideration of $152 million will be paid by Integer Holdings Corporation, subject to adjustment for additional contingent consideration. As part of consideration, $152 million is paid towards assets of Substantially All Assets of Precision Coating Company, Inc. Integer Holdings Corporation (NYSE:ITGR) completed the acquisition of Substantially All Assets of Precision Coating Company, Inc. on January 7, 2025. Piper Sandler Companies (NYSE:PIPR) acted as financial advisor to Precision Coating Company, Inc.
분석 기사 • Jan 28What Is Integer Holdings Corporation's (NYSE:ITGR) Share Price Doing?Integer Holdings Corporation ( NYSE:ITGR ), is not the largest company out there, but it saw a double-digit share price...
Recent Insider Transactions Derivative • Jan 24President exercised options and sold US$1.1m worth of stockOn the 21st of January, Joseph Dziedzic exercised options to acquire 8k shares at no cost and sold these for an average price of US$142 per share. This trade did not impact their existing holding. For the year to December 2018, Joseph's total compensation was 14% salary and 86% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since March 2024, Joseph's direct individual holding has increased from 222.32k shares to 224.21k. Company insiders have collectively sold US$8.1m more than they bought, via options and on-market transactions in the last 12 months.
공지 • Jan 23Integer Holdings Corporation to Report Q4, 2024 Results on Feb 20, 2025Integer Holdings Corporation announced that they will report Q4, 2024 results at 8:00 AM, US Eastern Standard Time on Feb 20, 2025
분석 기사 • Jan 14Here's Why Integer Holdings (NYSE:ITGR) Has Caught The Eye Of InvestorsThe excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
Recent Insider Transactions Derivative • Jan 07Key Executive exercised options and sold US$376k worth of stockOn the 3rd of January, John Harris exercised options to acquire 3k shares at no cost and sold these for an average price of US$134 per share. This trade did not impact their existing holding. Since March 2024, John's direct individual holding has increased from 1.47k shares to 1.52k. Company insiders have collectively sold US$7.5m more than they bought, via options and on-market transactions in the last 12 months.
분석 기사 • Jan 01Integer Holdings Corporation's (NYSE:ITGR) Share Price Matching Investor OpinionInteger Holdings Corporation's ( NYSE:ITGR ) price-to-earnings (or "P/E") ratio of 38.2x might make it look like a...
분석 기사 • Dec 04Returns On Capital At Integer Holdings (NYSE:ITGR) Have Hit The BrakesIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Reported Earnings • Oct 24Third quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behindThird quarter 2024 results: EPS: US$1.08 (up from US$0.82 in 3Q 2023). Revenue: US$431.4m (up 6.6% from 3Q 2023). Net income: US$36.3m (up 33% from 3Q 2023). Profit margin: 8.4% (up from 6.7% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 2.1%. Earnings per share (EPS) exceeded analyst estimates by 4.8%. Revenue is forecast to grow 6.6% p.a. on average during the next 3 years, compared to a 8.2% growth forecast for the Medical Equipment industry in the US. Over the last 3 years on average, earnings per share has increased by 9% per year whereas the company’s share price has increased by 11% per year.
공지 • Oct 24+ 1 more updateInteger Holdings Corporation Revises Earnings Guidance for the Year 2024Integer Holdings Corporation revised earnings guidance for the year 2024. For the year, company expected sales growth of 10% to 11% with above-market organic sales growth of 7% to 8%. Sales expected to be in range of $1,707 Million to $1,727 Million. Operating income to be in range of $205 Million to $213 Million. Diluted earnings per share to be in range of $3.42 Million to $3.61 Million. Unless otherwise stated, 2024 Outlook and comparisons are presented on a continuing operations basis. Company have raised the midpoint of full year profit and EPS outlook, compared to the 2024 outlook from July, revised to exclude Electrochem.
분석 기사 • Oct 18Integer Holdings (NYSE:ITGR) Has A Pretty Healthy Balance SheetLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
분석 기사 • Oct 05Is Now An Opportune Moment To Examine Integer Holdings Corporation (NYSE:ITGR)?Integer Holdings Corporation ( NYSE:ITGR ), is not the largest company out there, but it saw a decent share price...
Seeking Alpha • Oct 02Integer Holdings: More Than Re-Rated HereSummary Integer Holdings shares have surged over 25% this year due to resilient organic growth and margin expansion, leaving current valuation multiples demanding. The company, a major medical device manufacturer, has shown solid growth, with revenues doubling over the past decade to $1.6 billion in 2023. Despite a solid performance, Integer's high valuation multiples and leverage make me cautious, as recent bolt-on deals haven't significantly impacted the investment thesis. With shares trading at 25 times earnings and premium expectations, I see no reason to chase the stock at all-time highs for long-term risk-reward. Read the full article on Seeking Alpha
공지 • Sep 27Integer Holdings Corporation to Report Q3, 2024 Results on Oct 24, 2024Integer Holdings Corporation announced that they will report Q3, 2024 results at 8:00 AM, US Eastern Standard Time on Oct 24, 2024
분석 기사 • Sep 22Here's Why Integer Holdings (NYSE:ITGR) Has Caught The Eye Of InvestorsInvestors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
새 내러티브 • Sep 02Expanding In High-Growth Markets With Calculated Acquisitions Boosts Revenue Potential Strong customer demand and operational improvements are poised to drive significant revenue growth and expand operating margins.
분석 기사 • Aug 28Here's What To Make Of Integer Holdings' (NYSE:ITGR) Decelerating Rates Of ReturnIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
분석 기사 • Aug 16What You Can Learn From Integer Holdings Corporation's (NYSE:ITGR) P/EWith a price-to-earnings (or "P/E") ratio of 38.4x Integer Holdings Corporation ( NYSE:ITGR ) may be sending very...
Recent Insider Transactions • Aug 02Independent Director recently sold US$551k worth of stockOn the 31st of July, Jean Hobby sold around 5k shares on-market at roughly US$120 per share. This transaction amounted to 67% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth US$992k. Insiders have been net sellers, collectively disposing of US$2.9m more than they bought in the last 12 months.
Recent Insider Transactions Derivative • Aug 01Key Executive notifies of intention to sell stockJohn Harris intends to sell 3k shares in the next 90 days after lodging an Intent To Sell Form on the 30th of July. If the sale is conducted around the recent share price of US$124, it would amount to US$421k. Since March 2024, John's direct individual holding has increased from 1.47k shares to 4.92k. Company insiders have collectively sold US$5.0m more than they bought, via options and on-market transactions in the last 12 months.
분석 기사 • Jul 28Estimating The Fair Value Of Integer Holdings Corporation (NYSE:ITGR)Key Insights The projected fair value for Integer Holdings is US$120 based on 2 Stage Free Cash Flow to Equity Current...
Reported Earnings • Jul 26Second quarter 2024 earnings: EPS exceeds analyst expectationsSecond quarter 2024 results: EPS: US$0.93 (up from US$0.72 in 2Q 2023). Revenue: US$436.2m (up 9.0% from 2Q 2023). Net income: US$31.2m (up 30% from 2Q 2023). Profit margin: 7.2% (up from 6.0% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 3.8%. Revenue is forecast to grow 6.8% p.a. on average during the next 3 years, compared to a 8.3% growth forecast for the Medical Equipment industry in the US. Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has increased by 6% per year.
공지 • Jul 26Integer Holdings Corporation Provides Earnings Guidance for the Year 2024Integer Holdings Corporation provided earnings guidance for the year 2024. For the year, the company expects sales in the range of $1,735 million to $1,770 million, Operating income in the range of $202 million to $220 million, Net income in the range of $116 million to $130 million, Diluted earnings per share in the range of $3.26 to $3.67.
분석 기사 • Jul 12Is Integer Holdings (NYSE:ITGR) Using Too Much Debt?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...